chr19-38596446-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001042600.3(MAP4K1):c.1982C>G(p.Ala661Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001042600.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP4K1 | NM_001042600.3 | c.1982C>G | p.Ala661Gly | missense_variant | 26/31 | ENST00000396857.7 | NP_001036065.1 | |
MAP4K1-AS1 | NR_134907.1 | n.90+10G>C | intron_variant, non_coding_transcript_variant | |||||
MAP4K1 | NM_007181.6 | c.1982C>G | p.Ala661Gly | missense_variant | 26/32 | NP_009112.1 | ||
MAP4K1 | XM_011526404.2 | c.2102C>G | p.Ala701Gly | missense_variant | 27/32 | XP_011524706.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP4K1 | ENST00000396857.7 | c.1982C>G | p.Ala661Gly | missense_variant | 26/31 | 5 | NM_001042600.3 | ENSP00000380066 | P1 | |
MAP4K1-AS1 | ENST00000589557.1 | n.91+10G>C | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2022 | The c.1982C>G (p.A661G) alteration is located in exon 26 (coding exon 26) of the MAP4K1 gene. This alteration results from a C to G substitution at nucleotide position 1982, causing the alanine (A) at amino acid position 661 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.